Hunan Eneng Biopharmaceutical
Traditional Chinese Medicine (TCM) CXO and R&D services.
Date | Investors | Amount | Round |
---|---|---|---|
* | CNY100m | Series A | |
Total Funding | 000k |
Hunan Eneng Biopharmaceutical Co., Ltd., also known as Yi Neng Pharmaceutical, is a contract research organization (CRO) focused on Traditional Chinese Medicine (TCM). Founded in December 2009 by Dr. Yi Yueneng, the company provides end-to-end services for the development of new TCM and natural drugs. Dr. Yi holds a master's degree in Pharmaceutics and a Ph.D. in Pharmaceutical Analysis from Central South University and completed post-doctoral work at Fudan University.
Operating as a CXO (Contract Everything Organization), the firm offers a one-stop platform that encompasses research and development, clinical trials, and production technology empowerment for pharmaceutical companies globally. Its services cover the entire lifecycle of a drug, including pharmaceutical research, clinical study services from Phase II to IV, and post-launch research such as quality standard improvements and drug vigilance. The company has a particular focus on the development of classic TCM formulas, innovative TCM drugs, and hospital preparations. As of early 2023, the firm had worked on 83 classic prescriptions, 22 innovative TCM drugs, and successfully registered 56 hospital preparations.
The business model is based on providing specialized outsourced R&D and technical services to pharmaceutical companies and medical institutions, positioning it as a key support enterprise in the TCM industry. In March 2023, the company announced the completion of a Series A financing round of over 100 million yuan, led by the Guangdong Traditional Chinese Medicine Grand Health Fund, with participation from Whige Capital. This funding was intended to enhance its R&D capabilities and construct a smart Chinese medicine research and development base.
Keywords: Traditional Chinese Medicine, TCM, CXO, Contract Research Organization, CRO, new drug development, natural medicine, clinical trials, pharmaceutical services, classic prescriptions, hospital preparations, drug R&D, pharmaceutical technology, biopharmaceutical, herbal medicine, drug discovery, life sciences, healthcare innovation, China biopharma